Michael J. LaBarre, SVP, Chief Technical Officer: Halozyme Therapeutics HALO Sell · Filed 25/02/27

Trade details

Type: Insider sale
Amount: $5,874
Shares · price: 100 sh · $58.74 a share
Held after: 173,756 sh
Stock: Halozyme Therapeutics HALO
Person: Michael J. LaBarreSVP, Chief Technical Officer
Trade date: 25/02/27
Filed: 25/02/27
Days to filing: 0 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/28~25/03/29

Michael J. LaBarre's recent trades

Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$546K
9,400 sh
$546K
Filed 25/02/27
Traded 25/02/26
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$539.5K
9,300 sh
$539.5K
Filed 25/02/27
Traded 25/02/25
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$93K
1,597 sh
$93K
Filed 25/02/27
Traded 25/02/27
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$41.1K
700 sh
$41.1K
Filed 25/02/27
Traded 25/02/25
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$35.2K
600 sh
$35.2K
Filed 25/02/27
Traded 25/02/26

Michael J. LaBarre, Chief Officer — sold $5,874 of Halozyme Therapeutics HALO · 0.1% of holdings · 10b5-1 plan | Whalegun